Regulatory Applications

Richmond Pharmacology will undertake all regulatory matters on behalf of our clients, depending on their requirements.

Our experienced project management team will compile all necessary documentation, including writing the information for volunteers, informed consent form and completing the online IRAS application form.

Richmond Pharmacology can obtain necessary documentation and specialist opinions for ethics submissions, in order to obtain approvals in a timely manner. We work closely with many ethics committees, local and nationwide, and will select an ethics committee based on study needs.

If required, the Principal Investigator will attend the ethics committee meeting to participate in discussions and ensure a smooth approval process.

As well as working with many Phase I ethics committees, we also work closely with our local ethics committee which approves Phase II studies. If required, we will obtain R&D approval for a specific site, a process of which Richmond Pharmacology has extensive experience.

Richmond Pharmacology will also organise and oversee the CTA application to the MHRA if required. We have submitted numerous CTAs to the MHRA on behalf of our clients, typically gaining approval after the first review of the study documentation.

Latest news

Upcoming Event

The Future of Healthcare.

13:00 – 17:00, 8th December 2021
Join Richmond Pharmacology, The Royal Free Hospital and Richmond Research Institute as we share breakthroughs in cardiac health from gene editing to RNA interference therapies.
View event

The future of clinical workforce training programmes, an exclusive interview with MedCity

November 30, 2021
Ulrike Lorch discusses the future of clinical workforce training programmes in an exclusive interview with MedCity
Read more

Richmond Pharmacology’s Dr Emma Akuffo joins fellow EUCROF task force members as a finalist at TOPRA Awards 2021

November 17, 2021
EUCROF task force members compete for a prize at the TOPRA Awards 2021
Read more

Developing talent in the fast-changing clinical research environment

November 2, 2021
In a feature article for PharmaTimes, Dr. Ulrike Lorch, Medical Director at Richmond Pharmacology, outlines how investing in the clinical research workforce is crucial to delivering high quality, cutting-edge trials and achieving faster drug development
Read more